Uniphar (LON:UPR) Reaches New 52-Week Low – Time to Sell?

Uniphar plc (LON:UPR) reached a new 52-week low during trading on Wednesday . The stock traded as low as GBX 178 ($2.29) and last traded at GBX 180 ($2.32), with a volume of 14023 shares trading hands. The stock had previously closed at GBX 183.50 ($2.36).

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 310 ($3.99) price target on shares of Uniphar in a research report on Wednesday, September 4th.

Uniphar Stock Performance

The business’s 50 day simple moving average is GBX 207.56 and its 200 day simple moving average is GBX 214.36. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.43. The company has a market cap of £472.32 million, a P/E ratio of 1,235.71 and a beta of 0.75.

Uniphar Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, October 4th. Shareholders of record on Thursday, September 12th were paid a €0.01 ($0.01) dividend. The ex-dividend date was Thursday, September 12th. This represents a yield of 0.25%. Uniphar’s payout ratio is presently 1,428.57%.

Uniphar Company Profile

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.